Nancy Lynn was appointed Senior Vice President of the Arnold P. Gold Foundation (APGF) in January 2014. The APGF’s mission is to optimize the experience and outcomes of health care for both patients and practitioners by promoting care that is as humane as it is technologically sophisticated. The Foundation works with physicians in training and in practice, as well as other members of the healthcare team, to create a culture of respect, dignity and compassion for patients and professionals. Prior to joining the APGF, Ms. Lynn was Executive Director and Chief Operating Officer of the Alzheimer’s Drug Discovery Foundation (ADDF / 2009 – 2013), an organization founded and co-chaired by Leonard A. Lauder and Ronald S. Lauder working to accelerate the discovery of drugs to prevent, treat and cure Alzheimer’s disease, related dementias and cognitive aging.
From 1998 – 2009, Ms. Lynn worked at the American Museum of Natural History in New York City. Her service at the Museum included positions as Director of Global Business Development (supervising the licensing of scientific intellectual property and establishing collaborations with science institutions and government agencies worldwide) and Director of Corporate Relations. From 1996 – 2004, Ms. Lynn also served as a staff lecturer at The Cloisters, the branch of the Metropolitan Museum of Art devoted to the art and architecture of medieval Europe.
Ms. Lynn is a former member of the National Board of Trustees for the Crohn’s & Colitis Foundation of America and of the Board of Trustees for the Martha Graham Dance Company, New York. She has also served on leadership boards for the National Center for Science Education and the National Foundation for Advancement in the Arts. She is a founding member of WomenAgainstAlzheimer’s.
Ms. Lynn received a bachelor of arts in the history of art and architecture from Columbia University in New York (Valedictorian), and a master’s degree in the history of art and architecture from the Institute of Fine Arts, New York University.